• 제목/요약/키워드: Prostate-Specific Antigen (PSA)

검색결과 105건 처리시간 0.022초

테스토스테론-유도 양성전립선비대증에서 나노화 벌 화분의 효능 연구 (Beneficial Effects of Nano-sized Bee Pollen on Testosterone-induced Benign Prostatic Hyperplasia in Rodents)

  • 박지아;편해인;소수정;이승현;이승민;서화진;강재선;최윤식;정일경
    • 생명과학회지
    • /
    • 제28권4호
    • /
    • pp.465-471
    • /
    • 2018
  • 벌 화분은 오랫동안 전 세계적으로 이용되어 온 대체요법 중 하나이다. 벌 화분은 항진균 및 항균작용, 항암작용, 면역조절, 그리고 세포의 증식 등 다양한 생리활성을 갖고 있는 것으로 알려져 있다. 본 연구는 설치류를 이용하여 벌 화분의 양성전립선비대증의 개선 효과를 밝히기 위해 진행되었다. 벌 화분은 활성 성분의 추출률을 극대화하고, 생체 흡수율을 높이기 위하여 나노 크기로 분쇄하여 이용하였다. 먼저, 나노 크기의 벌 화분은 만성 testosterone 투여에 의한 전립선 크기 증가를 유의하게 완화하였다. 게다가 나노 크기의 벌 화분은 혈중 전립선 특이 항원의 농도를 뚜렷하게 감소시켰다. 흥미롭게도 나노 크기의 벌 화분은 testosterone에 의한 혈중 prostaglandin $E_2$ 증가에는 유의한 영향을 미치지 않았다. 이러한 나노 크기 벌 화분의 약리 효능은 dutasteride의 효과와 유사하였다. 마지막으로 나노 크기의 벌 화분은 androgen-반응성 인간 전립선 샘암종 세포인 LNCaP 세포의 손상을 유도하지 않았다. 이러한 결과를 종합하면, 나노화 된 벌 화분은 양성전립선비대증의 치료에 대체요법으로 이용될 수 있을 것으로 기대된다.

Resveratrol Inhibits IL-6-Induced Transcriptional Activity of AR and STAT3 in Human Prostate Cancer LNCaP-FGC Cells

  • Lee, Mee-Hyun;Kundu, Joydeb Kumar;Keum, Young-Sam;Cho, Yong-Yeon;Surh, Young-Joon;Choi, Bu Young
    • Biomolecules & Therapeutics
    • /
    • 제22권5호
    • /
    • pp.426-430
    • /
    • 2014
  • Prostate cancer is the most frequently diagnosed cancer. Although prostate tumors respond to androgen ablation therapy at an early stage, they often acquire the potential of androgen-independent growth. Elevated transcriptional activity of androgen receptor (AR) and/or signal transducer and activator of transcription-3 (STAT3) contributes to the proliferation of prostate cancer cells. In the present study, we examined the effect of resveratrol, a phytoalexin present in grapes, on the reporter gene activity of AR and STAT3 in human prostate cancer (LNCaP-FGC) cells stimulated with interleukin-6 (IL-6) and/or dihydrotestosterone (DHT). Our study revealed that resveratrol suppressed the growth of LNCaP-FGC cells in a time- and concentration-dependent manner. Whereas the AR transcriptional activity was induced by treatment with either IL-6 or DHT, the STAT3 transcriptional activity was induced only by treatment with IL-6 but not with DHT. Resveratrol significantly attenuated IL-6-induced STAT3 transcriptional activity, and DHT- or IL-6-induced AR transcriptional activity. Treatment of cells with DHT plus IL-6 significantly increased the AR transcriptional activity as compared to DHT or IL-6 treatment alone and resveratrol markedly diminished DHT plus IL-6-induced AR transcriptional activity. Furthermore, the production of prostate-specific antigen (PSA) was decreased by resveratrol in the DHT-, IL-6- or DHT plus IL-6-treated LNCaP-FGC cells. Taken together, the inhibitory effects of resveratrol on IL-6- and/or DHT-induced AR transcriptional activity in LNCaP prostate cancer cells are partly mediated through the suppression of STAT3 reporter gene activity, suggesting that resveratrol may be a promising therapeutic choice for the treatment of prostate cancer.

Analysis of the bcl-2, Ki-67 and p53 Expression Level Based on the Gleason Score Group of Prostate Adenocarcinoma

  • Kim, Tai-Jeon;Kim, Sung-Chul
    • 대한의생명과학회지
    • /
    • 제14권3호
    • /
    • pp.157-165
    • /
    • 2008
  • Recently, the number of patients with prostate cancer has been increased gradually by both the change of living environment and the increase of aged population. In this study the serum prostate specific antigen (PSA) level was compared to the Gleason score known as a prognostic factor for the prostate cancer. In the Gleason score 6 and $9{\sim}10$, the average age was 69.68 years old and 69.52 years old, respectively and there was no statistically difference in both of age and Gleason score. the PSA serum consistency appeared <4 ng/mL as example 1, $4{\sim}20ng/mL$ as example 17 and ${\geq}20ng/mL$ as example 4 in the Gleason score 6, and In the Gleason score $9{\sim}10$, it appeared <4 ng/mL as example 1, $4{\sim}20ng/mL$ as example 6 and ${\geq}20ng/mL$ as example 15. PSA serum consistency in the Gleason score $9{\sim}10$ showed higher value than those of Gleason score 6 (P<0.05). Next, expression ratios of bcl-2, Ki-67 and p53 were examined in the Gleason score 6 and $9{\sim}10$. the p53 expression ratio, a tumor suppression gene, appeared the significance statistically by the classification of the Gleason score as example 7 (28%) in the Gleason score 6 and as example 16 (64%) in the Gleason score $9{\sim}10$ (P<0.05). but not different in the expression ratios of the Ki-67 and bcl-2. The expression ratio of p53 by the expression ratio of bcl-2 and the expression ratio of Ki-67 by the expression ratio of p53 had a positive relationship in all of the Gleason score 6 and the Gleason score $9{\sim}10$ (P<0.05). However, the expression ratio of Ki-67 by the expression ratio of bcl-2 did not show any significance in the Gleason score $9{\sim}10$ (P<0.05). Therefore, the results suggested that p53 expression could be used as an independent prognostic factor.

  • PDF

가자(Terminalia chebula Retz.) 열매 메탄올 추출물의 Histone Acetyltransferase 활성 저해에 따른 항전립선암 효과 (The Inhibitory Effect on Androgen Receptor-Dependent Prostate Cancer Cell Growth by Anti-Histone Acetyltransferase Activity from Terminalia chebula Retz. Fruit Methanol Extract)

  • 이유현
    • 한국식품영양과학회지
    • /
    • 제42권10호
    • /
    • pp.1539-1543
    • /
    • 2013
  • 본 연구에서는 Terminalia chebula Retz.의 성숙열매인 가자 메탄올 추출물(TCME)을 이용하여 HAT 활성을 억제함으로써 AR의 아세틸화 감소를 유도하여 전립선암세포의 성장을 억제하였다. TCME의 처리는 HAT 활성을 100 ${\mu}g/mL$의 농도에서 50% 이상 저해하였으며, p300과 CBP 등의 특이적 HAT 단백질에서도 유의적인 저해활성을 보였다. TCME를 0~100 ${\mu}g/mL$로 안드로젠 수용체 의존적 전립선 암세포인 LNCaP에 처리한 결과, reporter assay에서 AR 매개 전사를 억제하고 AR target gene의 mRNA 발현을 억제하였다. 동일 농도에서 AR의 아세틸화가 감소한 결과를 보였으며, 결국 전립선암세포주의 성장억제를 유도하였다. 이같은 결과에서 가자 메탄올 추출물은 HAT 활성을 억제하며, AR의 아세틸화를 감소시킴으로써 효과적인 전립선암 치료소재로 개발될 수 있는 가능성이 있음을 제안한다.

Efficacy and Toxicity of Anti-VEGF Agents in Patients with Castration-Resistant Prostate Cancer: a Meta-analysis of Prospective Clinical Studies

  • Qi, Wei-Xiang;Fu, Shen;Zhang, Qing;Guo, Xiao-Mao
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권19호
    • /
    • pp.8177-8182
    • /
    • 2014
  • Background: Blocking angiogenesis by targeting vascular endothelial growth factor (VEGF) signaling pathway to inhibit tumor growth has proven to be successful in treating a variety of different metastatic tumor types, including kidney, colon, ovarian, and lung cancers, but its role in castration-resistant prostate cancer (CRPC) is still unknown. We here aimed to determine the efficacy and toxicities of anti-VEGF agents in patients with CRPC. Materials and Methods: The databases of PubMed, Web of Science and abstracts presented at the American Society of Clinical Oncology up to March 31, 2014 were searched for relevant articles. Pooled estimates of the objective response rate (ORR) and prostate-specific antigen (PSA) response rate (decline ${\geq}50%$) were calculated using the Comprehensive Meta-Analysis (version 2.2.064) software. Median weighted progression-free survival (PFS) and overall survival (OS) time for anti-VEGF monotherapy and anti-VEGF-based doublets were compared by two-sided Student's t test. Results: A total of 3,841 patients from 19 prospective studies (4 randomized controlled trials and 15 prospective nonrandomized cohort studies) were included for analysis. The pooled ORR was 12.4% with a higher response rate of 26.4% (95%CI, 13.6-44.9%) for anti-VEGF-based combinations vs. 6.7% (95%CI, 3.5-12.7%) for anti-VEGF alone (p=0.004). Similarly, the pooled PSA response rate was 32.4% with a higher PSA response rate of 52.8% (95%CI: 40.2-65.1%) for anti-VEGF-based combinations vs. 7.3% (95%CI, 3.6-14.2%) for anti-VEGF alone (p<0.001). Median PFS and OS were 6.9 and 22.1 months with weighted median PFS of 5.6 vs. 6.9 months (p<0.001) and weighted median OS of 13.1 vs. 22.1 months (p<0.001) for anti-VEGF monotherapy vs. anti-VEGF-based doublets. Conclusions: With available evidence, this pooled analysis indicates that anti-VEGF monotherapy has a modest effect in patients with CRPC, and clinical benefits gained from anti-VEGF-based doublets appear greater than anti-VEGF monotherapy.

토마토 추출액 복합체가 전립선 암 세포와 전립선 비대증에 미치는 영향 (The Effect of the Compound of Tomato Extract to the Prostatic Cancer Cell and the Prostate of the Rat Model of Benign Prostatic Hyperplasia)

  • 강한샘;김광윤;정일;오성덕;김창훈;심봉섭;박근형;오석중
    • 생약학회지
    • /
    • 제38권2호통권149호
    • /
    • pp.197-203
    • /
    • 2007
  • Benign prostatic hyperplasia (BPH) is one of the common disease in elderly men. Recently old-age population is increased and we are growing more and more interested in clinical importance of BPH. In this study, the effect of PLX, which was the mixture of tomato extract (including 2% of lycopene) and chitooligosaccharide, on prostatic cancer cell and testosterone-induced BPH in adult rats of the Sprague Dawley strain was determined. The cell viability was evaluated by MTT method using L929 and LNCaP cell line, pretreated with various concentrations of PLX. The expression of prostatic specific antigen (PSA) and 5${\alpha$}$-reductase genes were evaluated by realtime PCR using LNCaP cell line and compared various concentrations of PLX with 50 ${\mu}$M of finasteride. An experimental prostatic hyperplasia was induced in male Sprague Dawley rats by giving testosterone for 8 weeks. After 2 weeks from start of giving testosterone, PLX and finasteride were administered orally once a day. The results were analyzed with prostate weight per body weight at 8 weeks. Cell viability of L929 cell line decreased specifically at the concentration of 2000 ${\mu}$g/mf of PLX. The cytotoxicity of PLX to the LNCaP cell line was shown at above 500 ${\mu}$g/ml of PLX. The inhibitory effect of PLX to the expression of PSA and 5${\alpha$}$-reductase genes in LNCaP cell line increased with the concentration of PLX. In vivo study, the results of PLX and finasteride administered group were 3.75${\pm}$0.60 and 3.49${\pm}$0.49 prostate weight ${\times}10^3$/body weight, which were lower than the result of BPH induced group (4.74${\pm}$0.58). These results suggested that PLX may be an effective material in BPH by having the role of the 5a-reductase inhibitor.

핵의학 체외 검사에서 자동분주기를 이용한 Random Assay 가능성평가 (Comparison of Batch Assay and Random Assay Using Automatic Dispenser in Radioimmunoassay)

  • 문승환;이호영;신선영;민경선;이현주;장수진;강지연;이동수;정준기;이명철
    • Nuclear Medicine and Molecular Imaging
    • /
    • 제43권4호
    • /
    • pp.323-329
    • /
    • 2009
  • 목적: 방사면역측정법 및 면역방사계수법은 매 실험마다 표준용액을 넣고 표준곡선에 대비하여 결과를 산출하는 batch assay가 일반화되어 있다. 비용과 시간에 대한 효율성을 증가 시키기 위해서는 선행 표준 곡선을 이용하여 검사를 진행하는 random assay의 적용이 요구된다. 방사면역측정법 및 면역방사계수법에서 자동분주기를 이용한 random assay적용 가능성을 평가 하기 위해 본 연구를 수행하였다. 대상 및 방법: Triiodothyronine (T3), free thyroxine (fT4), Prostate specific antigen (PSA), Carcinoembryonic antigen (CEA) 4가지 항목을 대상으로 하였으며 각 검사별 20명의 환자 검체를 이용하였다. 각 검사 항목별로 표준곡선을 얻기 위해 3시간 간격으로 4회 측정한 표준용액의 분당계수값(counter per minute, cpm)을 측정하였다. 이를 Friedman test를 이용하여 비교하여 검사시 마다 얻는 표준 곡선간의 차이를 평가하였다. 각 검사별 저, 중, 고농도의 대조 용액을 이용하여 5회 측정하고 이를 Friedman test를 이용하여 비교하여 측정 내 정밀도를 평가하였다. 각 검사별 저, 중, 고농도의 대조용액을 batch assay와 자동분주기를 이용한 random assay로 3시간 간격으로 각각 4회 측정하였다. 측정값을 바탕으로 평균, 표준 편차, 변이계수를 구하고 Wilcoxon test를 이용하여 비교하여 assay 방법에 따른 차이를 비교하였다. 두 assay간에 일치도(agreement)를 평가하기 위해 두 assay의 측정값 사이에 급내상관계수(Intraclass correlation coefficient, ICC)와 상관계수를 계산하였다. 결과: 모든 검사항목에서 표준 용액의 분당계수값은 측정 간에 통계적으로 유의한 차이가 없었다. T3, fT4, PSA, CEA 검사항목마다 측정한 저, 중, 고농도별 측정 내 변이계수는 T3(3.6%, 2.6%, 0.9%), fT4(4.5%, 1.1%. 1.3%), PSA(3.9%, 3.1%, 1.2%), CEA(5.0%, 4.8%, 7.6%)였다. 검사 항목별 측정방법에 따른 대조 용액을 이용한 표준 곡선의 측정 간 정밀도 평가에서 두 검사 방법간에 유의한 차이가 없었다. 각 검사항목별로 20명의 환자 검체에서 측정한 측정 간 변이계수(inter-assay precision)의 평균과 표준편차 값은 batch assay로 시행했을 때 각각 3.2$\pm$1.7%, 3.9$\pm$2.1%. 7.1$\pm$6.2%, 11.2$\pm$7.2%였고 random assay로 측정하였을 때는 2.7$\pm$1.7%, 4.8$\pm$3.1%, 3.6$\pm$4.8%, 7.4$\pm$6.2였다. Batch assay와 random assay는 서로 높은 일치도를 보였다. 측정한 급내상관계수(Intraclass correlation coefficient)는 T3, fT4, PSA, CEA 각각 0.9968, 0.9973. 0.9996, 0.9901였다. Batch assay로 측정한 값과 자등분주기를 이용한 random assay로 측정한 값 사이에 상관 계수(R$^2$)는 T3, fT4, PSA, CEA 각각 0.9924, 0.9974, 0.9994, 0.9989(p<0.005)로 모두 강한 상관관계를 보였다. 결론: T3, fT4, PSA, CEA 4가지 항목의 방사면역측정 법 (Radioimmunoassay)에서 기존의 batch assay와 자동분주기를 이용한 random assay간에 일치도와 상관성이 높았다. 결론적으로 자동분주기를 이용한 random assay를 방사면역측정법 및 면역방사계수법에 적절히 이용할 수 있을 것으로 생각된다.

LNCaP 세포주를 이용한 내분비계장애물질중 안드로겐성 확인시험을 위한 검색법 (Screening Assay for Identification of Endocrine Disruptors with Androgen Activities using LNCaP Cells)

  • 김진호;정혜주;김영옥;정승태;박재현;조대현;김동섭
    • Toxicological Research
    • /
    • 제18권1호
    • /
    • pp.59-64
    • /
    • 2002
  • Substantial evidences have been accumulated about the hormone-like effects of exogenous substances such as pesticides and industrial chemicals during past years. The effects of these substances on the endocrine system are believed to be either enhancing or reducing of various endocrine action. It is necessary to identify putative causal agents by the batter system and to assess their ability to disrupt the endocrine system. A variety of in vitro and In vivo approaches have been used to determine the androgenic effects of environmental chemicals. To establish the method for assessment of the putative endocrine disruptors with androgenic activity, we carried out the cell proliferation assay by MTS method after treatment with the various concentration of testosterone in LNCaP cells (human prostatic cancer cell line) and also observed the expression of androgen-related genes by quantitative RT-PCR. In the cell proliferation assay, the results showed that the grouth of LNCaP cells increased within level of at least 10pM testosterone. We measured by quantitative RT-PCR method on the effects of testosterone on mRNA expression of androgen receptor (AR), prostate-specific antigen (PSA), bone morphogenetic protein (BMP) and BMP receptor (BMPR) In LNCaP cells. The results demonstrated that mRNA expression of PSA and BMPR-IB was observed differently within level of at least 0.01 pM testosterone compared with non-treated control. These observations suggest that the detection of PSA and BMPR-IB mRNA by the quantitative RT-PCR in LNCaP cells is very sensitive method to identify the endocrine disruptors to have the androgenic effects.

면역방사계수측정법의 민감도 향상을 위한 변법의 평가 (Evaluation of Variation Method to Improve the Sensitivity of Immunoradiometric Assay)

  • 권원현;강미지;김나경;박지솔;김정인;이경재
    • 핵의학기술
    • /
    • 제27권1호
    • /
    • pp.29-35
    • /
    • 2023
  • Purpose The concentration of PSA (Prostate Specific Antigen) after radical prostatectomy in prostate cancer patients is a predictor of biochemical recurrence, and the AUA (American Urological Association) is defined as biochemical recurrence when the concentration of PSA is measured at 0.2 ng/mL or more, and when the concentration is measured at 0.2 ng/mL or more at the retest. This standard is also applied our hospital. In this laboratory, the PSA reagent using IRMA (Immunoradiometric Assay) is used, and the sensitivity at a very low value was not as good as the reagent used in the department of laboratory medicine. This study aims to increase the reliability of the results by improving the precision and sensitivity of very low values. Materials and Methods As a reagent for the study, PSA reagent using IRMA was used. As a method to improve the precision and sensitivity of very low values, a variation method on the serum volume(25 uL, 50 uL, 100 uL, 200 uL) was studied, and variation usefulness evaluation was conducted. The evaluation items were compared the results of precision, analytical sensitivity, recovery rate, dilution test, high-dose hook effect test, parallel test and very low concentration values(n = 20). Results The validation results were displayed in the order of 25 uL, 50 uL, 100 uL, 200 uL. As the serum volume increased, it was confirmed that CV (Coefficient of Variation)(%) improved. Analytical sensitivity(ng/mL) was 0.038, 0.041, 0.017, 0.015 and recovery rate(%) was 101±3, 101±3, 99±2, 97±4. very low concentration values(ng/mL) between each volume(n=20) were 0.135±0.068, 0.076±0.050, 0.048±0.034, 0.046±0.034. and high dose hook effect appeared as the serum volume increased. Conclusion Through the variation usefulness evaluation, it was confirmed that as the serum volume increased, the precision and sensitivity improved at very low concentration values. However, it is necessary to pay special attention to the occurrence of high-dose hook effect as the serum volume increases. In the case of tests that requires very low concentration values, it is thought that the reliability of the result will be increased if the variation method is properly used after the variation usefulness evaluation.

  • PDF

한국에서 Biochemical Recurrence의 진단에 대한 혈액 및 영상의학적 검사에 관한 비뇨기종양을 전공하는 의사의 트렌드에 대한 고찰 (The Trend of Uro-Oncologist About Blood Test and Imaging Studies for the Diagnosis of Biochemical Recurrence in Korea)

  • 서성필;김원태;강호원;김용준;이상철;김원재;김소영;박종혁;윤석중
    • 대한비뇨기종양학회지
    • /
    • 제15권3호
    • /
    • pp.131-136
    • /
    • 2017
  • Purpose: The aim of this study is to investigate the criteria of biochemical recurrence (BCR) and follow-up periods and methods with and without blood and imaging test of urologic oncology before established guidelines of prostate cancer in Korea. Materials and Methods: In December 2015, we sent the questionnaire to urologic oncologist in academic hospital and received the answer from 108 urologic oncologist (50%). Also, we analyzed the data of 1,141 patients underwent radical prostatectomy in 2005 from Korean Medical Insurance. Results: In follow-up, 72 physicians (66.7%) performed blood test every 3 months, 51 physicians (47.2%) performed imaging study in case of BCR. Bone scan was the most common imaging study in the follow-up (74 physicians, 68.5%). But, bone scan was only performed in case of BCR (43 physicians, 39.8%). The criteria of BCR was PSA 0.2 ng/mL (75 physician, 69.4%), 76 physicians (70.4%) was performed different follow-up according to risk of patients. In Korean Medical Insurance data analysis, PSA were performed average 2 times every year and magnetic resonance imaging, computed tomography, Bone scan were performed average 0.1, 0.2, 0.1 times every year, respectively. Conclusions: The criteria of BCR and the follow-up of prostate cancer patients in Korea were similar Korean prostate cancer guidelines. Blood and imaging test might be increased compared to 10 years ago, it is necessary to compare the Korean Medical Insurance data between 10 years ago and present.